Featured Article

Research suggests that a ketogenic diet could counteract the reduced platelet counts often seen in cancer patients receiving chemotherapy.

Precision Oncology Today

Magazine

Is Clinical Next-Generation Sequencing on the Cusp of a Revolution?

Regardless of which test is used, it is likely NGS will be at the backbone of healthcare in future. So, is clinical NGS on the cusp of a revolution? Not quite yet—but watch this space.
Young male in stream of digital information

Twinning is Winning

As healthcare increasingly becomes informed by the analysis—via machine learning and artificial intelligence—of patient-specific, or disease-specific data, a new tool is steadily making its way onto the scene: patient digital twins. Digital twin technology promises to impact precision medicine from clinical trials to clinical care—in silico.
Escherichia coli bacteria

Translating the Microbiome

A flurry of microbiome research over the past two decades has led to many insights about the link between the microbes and health, but now the race to the clinic is on. Our understanding of the microbiome has been greatly advanced thanks to the improvements in next-generation sequencing techniques.

Trending on Inside Precision Medicine

Healthy keto breakfast, directly above view

Ketogenic Diet May Be Beneficial in Chemotherapy

Research suggests that a ketogenic diet could counteract the reduced platelet counts often seen in cancer patients receiving chemotherapy.
T cell attacking cancer cell, illustration

Tevogen Eyes Development of T Cells for Treatment of EBV-Related Cancers and MS

Tevogen announced it will begin work to study potential therapeutic use of its allogeneic genetically unmodified precision T cell technology in multiple sclerosis (MS) by developing Epstein-Barr virus (EBV) specific CD8+ cytotoxic T lymphocytes.

Gene Therapy Startup Partnered with Jim Wilson’s U Penn Program Nets $65M  

Gene editing start up iECURE announced a $65 million financing for its lead liver disease program, which is in partnership with Jim Wilson's group at University of Pennsylvania.

Daily News

Trending

Inside Precision Medicine